FDA Approved: CYRAMZA — Original Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved the original application for ramucirumab (CYRAMZA) by Eli Lilly for metastatic gastric or gastroesophageal junction adenocarcinoma, marking the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Cyramza (ramucirumab)

Snippet

ORIG AP for CYRAMZA (RAMUCIRUMAB)